HeartSciences Statistics

Total Valuation

HeartSciences has a market cap or net worth of $3.75 million. The enterprise value is $2.61 million.

Market Cap	3.75M
Enterprise Value	2.61M

Important Dates

The last earnings date was Monday, December 16, 2024, after market close.

Earnings Date	Dec 16, 2024
Ex-Dividend Date	n/a

Share Statistics

HeartSciences has 980,321 shares outstanding. The number of shares has increased by 637.06% in one year.

Current Share Class	980,321
Shares Outstanding	980,321
Shares Change (YoY)	+637.06%
Shares Change (QoQ)	+17.96%
Owned by Insiders (%)	8.69%
Owned by Institutions (%)	6.49%
Float	895,115

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	188.44
Forward PS	1.07
PB Ratio	0.90
P/TBV Ratio	1.55
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	177.26
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.72, with a Debt / Equity ratio of 0.72.

Current Ratio	1.72
Quick Ratio	1.23
Debt / Equity	0.72
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-26.71

Financial Efficiency

Return on equity (ROE) is -644.23% and return on invested capital (ROIC) is -128.39%.

Return on Equity (ROE)	-644.23%
Return on Assets (ROA)	-91.98%
Return on Capital (ROIC)	-128.39%
Revenue Per Employee	$980
Profits Per Employee	-$508,305
Employee Count	15
Asset Turnover	0.00
Inventory Turnover	0.01

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -76.97% in the last 52 weeks. The beta is 3.25, so HeartSciences's price volatility has been higher than the market average.

Beta (5Y)	3.25
52-Week Price Change	-76.97%
50-Day Moving Average	3.25
200-Day Moving Average	5.56
Relative Strength Index (RSI)	56.45
Average Volume (20 Days)	62,788

Short Selling Information

The latest short interest is 54,955, so 5.61% of the outstanding shares have been sold short.

Short Interest	54,955
Short Previous Month	30,472
Short % of Shares Out	5.61%
Short % of Float	6.14%
Short Ratio (days to cover)	2.41

Income Statement

In the last 12 months, HeartSciences had revenue of $14,700 and -$7.62 million in losses. Loss per share was -$10.54.

Revenue	14,700
Gross Profit	10,139
Operating Income	-7.47M
Pretax Income	-6.61M
Net Income	-7.62M
EBITDA	-7.43M
EBIT	-7.47M
Loss Per Share	-$10.54

Full Income Statement

Balance Sheet

The company has $4.05 million in cash and $2.90 million in debt, giving a net cash position of $1.15 million or $1.17 per share.

Cash & Cash Equivalents	4.05M
Total Debt	2.90M
Net Cash	1.15M
Net Cash Per Share	$1.17
Equity (Book Value)	4.02M
Book Value Per Share	4.24
Working Capital	2.39M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$7.88 million and capital expenditures -$60,750, giving a free cash flow of -$7.94 million.

Operating Cash Flow	-7.88M
Capital Expenditures	-60,750
Free Cash Flow	-7.94M
FCF Per Share	-$8.10

Full Cash Flow Statement

Margins

Gross Margin	68.97%
Operating Margin	-50,788.24%
Pretax Margin	-51,867.90%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

HeartSciences does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-637.06%
Shareholder Yield	-637.06%
Earnings Yield	-203.07%
FCF Yield	-211.49%

Analyst Forecast

The average price target for HeartSciences is $13.50, which is 252.48% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$13.50
Price Target Difference	252.48%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on May 17, 2024. It was a reverse split with a ratio of 0.01:1.

Last Split Date	May 17, 2024
Split Type	Reverse
Split Ratio	0.01:1

Scores

HeartSciences has an Altman Z-Score of -14.77 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-14.77
Piotroski F-Score	3